AAAAAA

   
Results: 1-8 |
Results: 8

Authors: HALFON P OUZAN D KHIRI H FERYN JM DESMORAT H BOURLIERE M BOYER N FONTANGES T MATHIEUCHANDELIER C JACQUES JP BAESJOUR S ROUHIER D LOUVET H HANSLIK B BEORCHIA S ANTONI M BRUNERIE M CORCOS D RICHARDMOLARD B PIERRUGUES R CAUCANAS J JOUANOLLE H
Citation: P. Halfon et al., SEROTYPING AND GENOTYPING OF HEPATITIS-C VIRUS (HCV) STRAINS IN CHRONIC HCV INFECTION, Journal of medical virology, 52(4), 1997, pp. 391-395

Authors: POUPON RE HUET PM POUPON R BONNAND AM VANNHIEU JT ZAFRANI ES BRESSONHADNI S MIGUET JP MATHIEUCHANDELIER C DOFFOEL M VETTER D ZARSKI JP PARIENTE EA CAPRON JP GRANGE JD DAVID A DEGOS F BOUNIN M DHUMEAUX D ZAFRANI ES MYARA A GUECHOT J
Citation: Re. Poupon et al., A RANDOMIZED TRIAL COMPARING COLCHICINE AND URSODEOXYCHOLIC ACID COMBINATION TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS, Hepatology, 24(5), 1996, pp. 1098-1103

Authors: OUZAN D DESMORAT H BOURLIERE M BALDINI E BOYER N FONTANGES T MATHIEUCHANDELIER C JACQUES JP BAESJOU S ROUHIER D LOUVET H HANSLIK B BEORCHIA S ANTONI M BRUNERIE M CORCOS D RICHARDMOLARD B PIERRUGUES R CAUCANAS J JOUANOLLE H DUMANOIR C LANGLOIS C LEMONNIER C KHIRI H BRICHETTI A HALFON P
Citation: D. Ouzan et al., SUSTAINED RESPONSE TO INTERFERON-ALFA 2B IS AFFECTED BY DOSE AND DURATION OF THERAPY - PRELIMINARY-RESULTS OF A FRENCH MULTICENTER RANDOMIZED TRIAL, Hepatology, 24(4), 1996, pp. 1727-1727

Authors: MAULIN L HACHULLA E MATHIEUCHANDELIER C CORTOT A PARIS JC DEVULDER B
Citation: L. Maulin et al., PRIMARY BILIARY-CIRRHOSIS WITH SYSTEMIC M ANIFESTATIONS OR ADULT-ONSET STILL DISEASE WITH HEPATITIS FIBROSIS, La Revue de medecine interne, 17(1), 1996, pp. 85-88

Authors: POUPON RE NIARD AM HUET PM MIGUET JP MATHIEUCHANDELIER C DOFFOEL M ZARSKI JP PARIENTE EA CAPRON JP GRANGE JD DEGOS F DHUMEAUX D ZAFRANI ES POUPON R
Citation: Re. Poupon et al., A RANDOMIZED TRIAL COMPARING THE COMBINATION URSODEOXYCHOLIC ACID (UDCA) AND COLCHICINE TO UDCA ALONE IN PRIMARY BILIARY-CIRRHOSIS, Hepatology, 20(4), 1994, pp. 10000151-10000151

Authors: VALLA D BABANY G OUZAN D TREPO C BOURLIERE M CALES P PAYEN JL COUZIGOU P BUFFET C MICHEL P VEYRAC M BERCOFF E LEVY VG PARIS JC GRANGE JD VALLA A FISCHER D EUGENE C DENIS J VOIGT JJ FABRE M LECHARPENTIER Y OPOLON P VALARD S GAUTHIER A PASCAL JP PELLETIER G COLIN R MICHEL H BOURREILLE J GUIVARCH P MATHIEUCHANDELIER C BODIN F LABAYLE D DAO T ANCIAUX ML
Citation: D. Valla et al., PREVENTION OF RELAPSE IN PATIENTS WITH CHRONIC NON-A, NON-B C HEPATITIS WHO RESPOND TO ALPHA-INTERFERON - A CONTROLLED MULTICENTER TRIAL OFLOW-DOSE MAINTENANCE THERAPY/, Journal of hepatology, 21(5), 1994, pp. 774-778

Authors: POUPON RE POUPON R BALKAU B HUET PM WILLEMS B MATHIEUCHANDELIER C PARIS JC MATHIEXFORTUNET H CAPRON JP CAPRON D DHUMEAUX D METREAU JM DEUGNIER Y OPOLON P BOUSQUET O PAYEN JL BRESSONHADNI S MIGUET JP DEGOS F BEAUGRAND M TRINCHET JC BLANC F CASSAN P GINESTON JL MORIN T PARELON G MICHEL H ETIENNE JP BUFFET C COUZIGOU P LEVYBRUHL A PARIENTE EA VALLA A VERWAERDE JC CHAPUT JC POYNARD T GAUTHIER A LEVY VG PAUMGARTNER G NIARD AM ESCHWEGE E ATLAN P ATTALI P
Citation: Re. Poupon et al., URSODIOL FOR THE LONG-TERM TREATMENT OF PRIMARY BILIARY-CIRRHOSIS, The New England journal of medicine, 330(19), 1994, pp. 1342-1347

Authors: OUZAN D SKAF R ANDREANI T OPOLON P TREPO C MICHEL P COUZIGOU P DUFFAUT M MARCELLIN P ZARSKI JP LEVY VG BERNARD P MATHIEUCHANDELIER C EUGENE C GRANGE JD GAUTHIER A VALLA A CAMATTE P POUPON R VALLA D PARIS JC OLIVARES R BABANY G
Citation: D. Ouzan et al., SERUM ALT ACTIVITY AFTER ONE MONTH TREATMENT IS THE BEST PREDICTIVE FACTOR OF EARLY AND LONG-TERM RESPONSE TO INTERFERON-ALPHA-2A IN CHRONIC HEPATITIS-C - A MULTIVARIATE-ANALYSIS ON 295 TREATED PATIENTS, Hepatology, 18(4), 1993, pp. 10000248-10000248
Risultati: 1-8 |